360 related articles for article (PubMed ID: 15233723)
21. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.
Allan RS; Waithman J; Bedoui S; Jones CM; Villadangos JA; Zhan Y; Lew AM; Shortman K; Heath WR; Carbone FR
Immunity; 2006 Jul; 25(1):153-62. PubMed ID: 16860764
[TBL] [Abstract][Full Text] [Related]
22. The cross-priming pathway: a portrait of an intricate immune system.
Basta S; Alatery A
Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
[TBL] [Abstract][Full Text] [Related]
23. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens.
Qiu CH; Miyake Y; Kaise H; Kitamura H; Ohara O; Tanaka M
J Immunol; 2009 Apr; 182(7):4127-36. PubMed ID: 19299710
[TBL] [Abstract][Full Text] [Related]
24. CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.
Backer R; van Leeuwen F; Kraal G; den Haan JM
Eur J Immunol; 2008 Feb; 38(2):370-80. PubMed ID: 18200498
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
[TBL] [Abstract][Full Text] [Related]
26. Cellular mechanisms governing cross-presentation of exogenous antigens.
Ackerman AL; Cresswell P
Nat Immunol; 2004 Jul; 5(7):678-84. PubMed ID: 15224093
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.
Villadangos JA; Schnorrer P
Nat Rev Immunol; 2007 Jul; 7(7):543-55. PubMed ID: 17589544
[TBL] [Abstract][Full Text] [Related]
28. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
[TBL] [Abstract][Full Text] [Related]
29. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
30. Antigen-presentation properties of plasmacytoid dendritic cells.
Villadangos JA; Young L
Immunity; 2008 Sep; 29(3):352-61. PubMed ID: 18799143
[TBL] [Abstract][Full Text] [Related]
31. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells.
Villadangos JA; Heath WR; Carbone FR
Trends Immunol; 2007 Feb; 28(2):45-7. PubMed ID: 17197240
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.
Dao T; Gomez-Nunez M; Antczak C; Kappel B; Jaggi JS; Korontsvit T; Zakhaleva V; Scheinberg DA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8763-72. PubMed ID: 16361564
[TBL] [Abstract][Full Text] [Related]
33. Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules.
Monu N; Trombetta ES
Curr Opin Immunol; 2007 Feb; 19(1):66-72. PubMed ID: 17157489
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
35. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
[TBL] [Abstract][Full Text] [Related]
36. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells.
Han S; Song Y; Lee YH; Lee YR; Lee CK; Cho K; Kim K
Cytokine; 2005 Dec; 32(5):187-93. PubMed ID: 16303313
[TBL] [Abstract][Full Text] [Related]
37. Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC.
Chen L; Fredholm BB; Jondal M
Mol Immunol; 2008 Apr; 45(8):2247-54. PubMed ID: 18178251
[TBL] [Abstract][Full Text] [Related]
38. New tools for antigen delivery to the MHC class I pathway.
Morón G; Dadaglio G; Leclerc C
Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
[TBL] [Abstract][Full Text] [Related]
39. Cross-presentation by human dendritic cell subsets.
Segura E; Amigorena S
Immunol Lett; 2014; 158(1-2):73-8. PubMed ID: 24333339
[TBL] [Abstract][Full Text] [Related]
40. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
